Teriprexine is usually administered via intravenous injection or infusion. Common usage is as follows:
Initial dose: 2 mg intravenously
Maintenance dose: 1–2 mg every 4–6 hours
Dosage adjusted according to the patient's condition
In the treatment of hepatorenal syndrome, it is usually necessary to use it continuously for several days, in conjunction with albumin infusion to enhance efficacy.
It is important to note that the patient's vital signs, including changes in blood pressure, heart rate, and urine output, should be closely monitored during administration to assess treatment efficacy and safety.